glp-1 receptor agonists and cardiovascular outcome trials an update Beyond GLP1: modulating multiple nutrient-stimulated hormone pathways to reduce risk Glucagon-like peptide 1 receptor agonists:

BMJ Med 1(1):e000308 Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX et al (2015) Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)

GLP-1, like other small peptides, is typically manufactured using chemical synthesis

Novel therapeutic approaches in diabetes

doi: 10.7570/jomes23052

Ask Your Doctor About Compounded GLP-1 Drugs Megan Wyatt, 43, of China Grove, North Carolina, considered compounded semaglutide after her employer-provided insurance plan suddenly revoked coverage

Rare but serious risks involve pancreatitis and gallbladder disease